Alpha memo: omega fatty acids atrial evidence boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Extract and report the actual FORWARD trial outcome (primary endpoint result, p-value, effect size) from the source bundle or full text; the memo cannot assert 'may fail or null out' without quoting the result.
2. Explicitly distinguish indication (post-CABG primary prevention vs. persistent AF recurrence secondary prevention), formulation/dose, and duration, and explain why the contexts are comparable enough to constitute a 'boundary' rather than simply different indications.
3. Acknowledge the 2008 receipt's design limitations (likely non-randomized, open-label, single-center, modest n) and temper the 'expectation' it set accordingly.
4. Add at minimum one corroborating or contradicting meta-analysis or guideline statement to contextualize whether the FORWARD result is anomalous or part of a known pattern of null omega-3 AF trials.
5. Define 'context_boundary geometry' or replace with standard scientific framing of indication-dependent efficacy.

Major issues

• The central claim is that the same intervention 'may fail or null out' across contexts, but the memo provides no data on FORWARD trial results, effect sizes, or outcome direction—only trial metadata and a truncated excerpt. The 'update' is asserted, not demonstrated.
• Receipt 1 (2008 CABG study) is a non-randomized or single-arm efficacy study of 189 patients with positive findings for reducing postoperative AF, while Receipt 2 (FORWARD 2012) is a RCT for recurrent symptomatic AF in persistent AF patients. The contexts are structurally different: primary prevention post-surgical vs. secondary prevention of recurrent AF in established disease. The memo's 'context_boundary geometry' framing overstates a fundamental population/indication mismatch as a paradox.
• The alpha memo makes a claim ('may fail or null out') without citing any result from FORWARD. This is source-grounded in title/metadata only, not in evidence direction. The 'surprise' is constructed from titles rather than from actual findings.
• The 2008 receipt's status as primary evidence for omega-3 efficacy is weak (open-label, single-center Russian journal, modest sample) and the memo does not flag this asymmetry when declaring it set up an expectation.

Minor issues

• The memo frames 'context_boundary' as novel geometry but does not operationalize or justify why this is more than a standard subgroup/indication contrast.
• Search receipt metadata (hits=10, shards=1525/1525, papers_searched=1456919317) is uninterpretable and adds no value.
• Domain slug 'longevity_research' does not match the cardiology/AF focus of the evidence.
• The 'falsifiers' section is generic boilerplate rather than study-specific.

Reviewer note

The memo attempts to identify a bounded signal—that omega-3 PUFA efficacy in AF may depend heavily on clinical context—but the execution fails to substantiate its central claim. The FORWARD excerpt is truncated before the results section, so the memo asserts an 'update' without quoting any actual outcome. The 2008 CABG study and FORWARD differ on multiple axes (primary vs. secondary prevention, post-surgical vs. persistent AF, short perioperative course vs. long-term maintenance), so framing this as a context-boundary paradox rather than simply two different indications is overclaim. The synthesis is shallow: two receipt summaries plus boilerplate falsifiers, no integration of effect sizes, populations, or mechanistic reasoning. Source grounding is partial—DOIs and titles match real papers, but the 'failure/null' direction for FORWARD is not extractable from the provided bundle. Revise is warranted because the underlying question (indication-dependent efficacy of omega-3 in AF) is legitimate and the sources exist, but the memo needs actual results extraction, clearer framing of why these two studies are comparable, and tempering of the paradox language.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis